Skip to main content
. 2020 Jul 2;47(5):461–471. doi: 10.1007/s10928-020-09697-x

Fig. 5.

Fig. 5

Estimated population mean disease progression rate (latent variable/year) and Symptomatic drug effect estimates and 95% CI (shaded area) for observed motor subscale data at each level of reduced information content with least informative(left panel), Most Informative(right panel) removed first